These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1719 related items for PubMed ID: 20385246

  • 1. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 2. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
    Shin J, Lee SY, Kim SH, Kim YB, Cho SJ.
    Neuroimage; 2008 Nov 01; 43(2):236-44. PubMed ID: 18694837
    [Abstract] [Full Text] [Related]

  • 3. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    N Engl J Med; 2006 Dec 21; 355(25):2652-63. PubMed ID: 17182990
    [Abstract] [Full Text] [Related]

  • 4. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014 Dec 21; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 5. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
    Ercoli LM, Small GW, Siddarth P, Kepe V, Huang SC, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Silverman DH.
    Int J Geriatr Psychiatry; 2012 Oct 21; 27(10):1017-27. PubMed ID: 22383132
    [Abstract] [Full Text] [Related]

  • 6. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL.
    Brain; 2014 Jun 21; 137(Pt 6):1762-71. PubMed ID: 24681664
    [Abstract] [Full Text] [Related]

  • 7. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.
    Eur J Nucl Med Mol Imaging; 2012 Dec 21; 39(12):1927-36. PubMed ID: 22926714
    [Abstract] [Full Text] [Related]

  • 8. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E, Förster S, Grimmer T, Tahmasian M, Yakushev I, Sorg C, Yousefi BH, Drzezga A.
    Brain Connect; 2014 Jun 21; 4(5):371-83. PubMed ID: 24870443
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
    Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC.
    Neuroimage; 2006 Oct 15; 33(1):94-102. PubMed ID: 16905334
    [Abstract] [Full Text] [Related]

  • 10. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
    Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G.
    J Nutr Health Aging; 2008 Jan 15; 12(1):61S-5S. PubMed ID: 18165848
    [Abstract] [Full Text] [Related]

  • 11. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO.
    Arch Neurol; 2008 Oct 15; 65(10):1304-9. PubMed ID: 18695050
    [Abstract] [Full Text] [Related]

  • 12. The merits of FDDNP-PET imaging in Alzheimer's disease.
    Shin J, Kepe V, Barrio JR, Small GW.
    J Alzheimers Dis; 2011 Oct 15; 26 Suppl 3():135-45. PubMed ID: 21971458
    [Abstract] [Full Text] [Related]

  • 13. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST.
    Brain; 2008 Jun 15; 131(Pt 6):1630-45. PubMed ID: 18339640
    [Abstract] [Full Text] [Related]

  • 14. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
    Förster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P, Wester HJ, Förstl H, Kurz A, Dickerson BC, Bartenstein P, Drzezga A.
    Biol Psychiatry; 2012 May 01; 71(9):792-7. PubMed ID: 21679929
    [Abstract] [Full Text] [Related]

  • 15. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.
    Neuroimage; 2008 Jan 15; 39(2):619-33. PubMed ID: 17962045
    [Abstract] [Full Text] [Related]

  • 16. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.
    Neuroimage Clin; 2015 Jan 15; 9():592-8. PubMed ID: 26640770
    [Abstract] [Full Text] [Related]

  • 17. Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI.
    He W, Liu D, Radua J, Li G, Han B, Sun Z.
    Cell Biochem Biophys; 2015 Jan 15; 71(1):17-26. PubMed ID: 25370296
    [Abstract] [Full Text] [Related]

  • 18. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
    Ito H, Shinotoh H, Shimada H, Miyoshi M, Yanai K, Okamura N, Takano H, Takahashi H, Arakawa R, Kodaka F, Ono M, Eguchi Y, Higuchi M, Fukumura T, Suhara T.
    Eur J Nucl Med Mol Imaging; 2014 Apr 15; 41(4):745-54. PubMed ID: 24233004
    [Abstract] [Full Text] [Related]

  • 19. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
    Driscoll I, Troncoso JC, Rudow G, Sojkova J, Pletnikova O, Zhou Y, Kraut MA, Ferrucci L, Mathis CA, Klunk WE, O'Brien RJ, Davatzikos C, Wong DF, Resnick SM.
    Acta Neuropathol; 2012 Dec 15; 124(6):823-31. PubMed ID: 22864813
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S.
    Semin Nucl Med; 2011 Jul 15; 41(4):283-99. PubMed ID: 21624562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.